Clinical trial
Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With…
NCT00423605 · Jazz Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00423605 |
|---|---|
| Title | Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia. |
| Official title | A Long-Term, Open-Label, Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia. |
| Lead sponsor | Jazz Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Fibromyalgia |
| Intervention type | Drug |
| Interventions | Xyrem® |
| Enrollment | 560 |
| Start date | Dec 1, 2006 |
| Primary completion | Jan 1, 2010 |
| Completion | Jan 1, 2010 |
| First posted | Jan 18, 2007 |
| Last update posted | Mar 30, 2012 |
| Countries | France, Germany, Italy, Netherlands, Spain, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: